Evidence map›Paper›PMID 28798976›Full record

ArticlePsychopharmacology2017

5-HT modulation of pain perception in humans.

Sarah L Martin, Andrea Power, Yvonne Boyle, Ian M Anderson, Monty A Silverdale, Anthony K P Jones

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Does the addition of peripheral nerve blocks improve analgesia during distal radius fracture reduction? A prospective, randomized, multicenter clinical trial.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Trial
  2. The Effect ofNutrients · 2026
    Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Involvement of 5-HTFrontiers in neuroscience · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Depression and Pain: Use of Antidepressants.Current neuropharmacology · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarah L MartinThe Human Pain Research Group, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. sarah.martin-10@postgrad.manchester.ac.uk.ORCID http://orcid.org/0000-0001-6382-3977
Andrea PowerThe Human Pain Research Group, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Yvonne BoyleGlaxoSmithKline Clinical Unit Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Ian M AndersonNeuroscience and Psychiatry Unit, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Monty A SilverdaleDivision of Neuroscience and Experimental Psychology, School of Biological Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Anthony K P JonesThe Human Pain Research Group, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Manchester Academic Health Science Centre · GBUniversity of Manchester · GBGlaxoSmithKline (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough there is clear evidence for the serotonergic regulation of descending control of pain in animals, little direct evidence exists in humans. The majority of our knowledge comes from the use of serotonin (5-HT)-modulating antidepressants as analgesics in the clinical management of chronic pain.

objectivesHere, we have used an acute tryptophan depletion (ATD) to manipulate 5-HT function and examine its effects of ATD on heat pain threshold and tolerance, attentional manipulation of nociceptive processing and mood in human volunteers.

methodsFifteen healthy participants received both ATD and balanced amino acid (BAL) drinks on two separate sessions in a double-blind cross-over design. Pain threshold and tolerance were determined 4 h post-drink via a heat thermode. Additional attention, distraction and temperature discrimination paradigms were completed using a laser-induced heat pain stimulus. Mood was assessed prior and throughout each session.

resultsOur investigation reported that the ATD lowered plasma TRP levels by 65.05 ± 7.29% and significantly reduced pain threshold and tolerance in response to the heat thermode. There was a direct correlation between the reduction in total plasma TRP levels and reduction in thermode temperature. In contrast, ATD showed no effect on laser-induced pain nor significant impact of the distraction-induced analgesia on pain perception but did reduce performance of the painful temperature discrimination task. Importantly, all findings were independent of any effects of ATD on mood.

conclusionAs far as we are aware, it is the first demonstration of 5-HT effects on pain perception which are not confounded by mood changes.

Indexed as

BeveragesAdultAffectAttentionCross-Over StudiesDouble-Blind MethodFemaleHumansMalePain MeasurementPain PerceptionSerotoninTryptophanSerotoninTryptophanAcute tryptophan depletion (ATD)PainSerotoninTryptophan

Identifiers

PMID28798976
PMCPMC5591803
OpenAlexW2736212031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.